Case Report
Labor Analgesia in Brugada Syndrome and the Importance of Contingency Planning
Table 1
Previous reports of central neuraxial anesthesia in parturients with Brugada syndrome, with the various medications and dosages used.
| Author | Year published | Central neuraxial technique | Medications administered | Dose |
| Kloesel [24] | 2011 | Epidural | Sufentanil | 5 μg | 1% 2-Chlorprocaine | 70 mg | Fentanyl-0.125% bupivacaine | n/a | Bupivacaine 0.125% (bolus) | 12.5 mg |
| Van de Knijff-van Dortmont [22] | 2016 | Epidural | 1 μg/mL Sufentanil-0.1% ropivacaine | n/a |
| Bramall [19] | 2016 | Spinal | 0.5% bupivacaine | 13.5 mg | Diamorphine | 400 μg |
| Dawe [25] | 2018 | Spinal | 0.5% bupivacaine | 12.5 mg | Diamorphine | 400 μg |
| Anaesthesia, (Abstracts) [26] | 2019 | Spinal | Bupivacaine | 1.5 mL | Diamorphine | 300 μg |
| Marques da Costa [27] | 2019 | Combined spinal-epidural | 0.75% ropivacaine | 13.5 mg | Sufentanil | 2.5 μg |
| Ranji [28] | 2020 | Spinal | Bupivacaine 0.75% | 10.5 mg | Fentanyl | 15 μg | Morphine | 150 μg |
| Sleipness [21] | 2020 | Combined | 2 μg/mL Fentanyl-0.125% | n/a | Spinal-epidural | ropivacaine |
|
|
Denotes an unknown concentration of the listed medication. |